Poly(ADP-Ribose) Polymerase 1 Promotes Inflammation and Fibrosis in a Mouse Model of Chronic Pancreatitis

• Published in: International journal of molecular sciences 2021-03, Vol.22 (7), p.3593
• Main Authors: El-Hamoly, Tarek, Hajnády, Zoltán, Nagy-Pénzes, Máté, Bakondi, Edina, Regdon, Zsolt, Demény, Máté A, Kovács, Katalin, Hegedűs, Csaba, Abd El-Rahman, Sahar S, Szabó, Éva, Maléth, József, Hegyi, Péter, Virág, László
• Format: Article
• Language: English
• Subjects: Acinar cells; Acinar Cells - metabolism; Actin; Acute Disease; Animal models; Animals; Apoptosis; Atrophy; Cell adhesion & migration; Cell death; Ceruletide - pharmacology; chronic pancreatitis; Collagen; Cytokines; Deoxyribonucleic acid; Disease Models, Animal; DNA; DNA damage; Extracellular matrix; Fibrosis; Gene expression; Inflammation; Inflammation - pathology; Inflammatory diseases; Inflammatory response; Interleukin 6; Interleukin-6 - metabolism; Leukocytes (granulocytic); Lungs; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morphology; Muscles; Mutation; Obstructions; Pancreas; Pancreas - metabolism; Pancreatitis; Pancreatitis - immunology; Pancreatitis - physiopathology; Pancreatitis, Chronic - pathology; Peptides; Peroxidase; Poly (ADP-Ribose) Polymerase-1 - metabolism; Poly (ADP-Ribose) Polymerase-1 - physiology; Poly(ADP-ribose); Poly(ADP-ribose) polymerase; poly(ADP-ribose) polymerase 1; Poly(ADP-ribose) Polymerase Inhibitors - pharmacology; Poly(ADP-ribose) Polymerases - metabolism; Proteins; Ribose; Rodents; Smooth muscle; Toxicity; Transcription factors; Transforming Growth Factor beta - metabolism; Tumor Necrosis Factor-alpha - metabolism; Tumor necrosis factor-α
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms22073593

Chronic pancreatitis (CP) is an inflammatory disease of the pancreas characterized by ductal obstructions, tissue fibrosis, atrophy and exocrine and endocrine pancreatic insufficiency. However, our understanding is very limited concerning the disease's progression from a single acute inflammation, via recurrent acute pancreatitis (AP) and early CP, to the late stage CP. Poly(ADP-ribose) polymerase 1 (PARP1) is a DNA damage sensor enzyme activated mostly by oxidative DNA damage. As a co-activator of inflammatory transcription factors, PARP1 is a central mediator of the inflammatory response and it has also been implicated in acute pancreatitis. Here, we set out to investigate whether PARP1 contributed to the pathogenesis of CP. We found that the clinically used PARP inhibitor olaparib (OLA) had protective effects in a murine model of CP induced by multiple cerulein injections. OLA reduced pancreas atrophy and expression of the inflammatory mediators TNFα and interleukin-6 (IL-6), both in the pancreas and in the lungs. Moreover, there was significantly less fibrosis (Masson's trichrome staining) in the pancreatic sections of OLA-treated mice compared to the cerulein-only group. mRNA expression of the fibrosis markers TGFβ, smooth muscle actin (SMA), and collagen-1 were markedly reduced by OLA. CP was also induced in PARP1 knockout (KO) mice and their wild-type (WT) counterparts. Inflammation and fibrosis markers showed lower expression in the KO compared to the WT mice. Moreover, reduced granulocyte infiltration (tissue myeloperoxidase activity) and a lower elevation of serum amylase and lipase activity could also be detected in the KO mice. Furthermore, primary acinar cells isolated from KO mice were also protected from cerulein-induced toxicity compared to WT cells. In summary, our data suggest that PARP inhibitors may be promising candidates for repurposing to treat not only acute but chronic pancreatitis as well.